APOBEC3A and breast cancer: Consistent with the observation of APOBEC-mutational signature, our results showed that germline APOBEC3A/B deletion was significantly associated with increased neoantigen loads only in breast cancer (P = 6.5 × 10− 3; Fig. 3c), while an opposite trend was observed in many other cancer types (Additional file 1: Table S8).